# IMPLEMENTATION BLUEPRINT
## Become the best page on the internet for: **Moringa patches (do they work?)**

**Page:** `/blog/moringa-patches-australia-review-do-they-work`  
**Constraint for this exercise:** Treat this as the **only page on the website**. Anything users or AI need must live *here* (or be an embedded primary artifact), not “see our other guide.”  
**Do NOT rewrite yet.** This is the blueprint only.  
**Date:** 22 July 2026  

**Topic definition (what “best” means):**  
Best = the single URL a skeptical Australian (or global) searcher should open to decide whether Glorenda / Healrize / Clearena / “moringa berberine patches” work, whether they’re safe, what TGA/ARTG status means, what happens if they already bought a pack, and what evidence-backed alternative exists — with verifiable sources, primary artifacts, and no need to open YouTube anecdotes or Trustpilot hype.

**Current SERP reality (evidence):** For “do moringa patches work,” top results include Trustpilot, Medical News Today (generic weight-loss patches), Amazon product pages, Reddit, affiliate Glorenda threads, YouTube. Your page’s job is to beat **anecdote + retail** with **evidence + AU regulation + brand-specific clarity**.

---

# 0. PAGE CHROME (Title / Meta / H1 / OG)

### Current problem
- Title 89 chars: `Moringa Patches Australia 2026: Do They Work or Is It a Scam? (Glorenda, Healrize Review)` — brands truncated in many SERPs; “scam” oversells vs body nuance.
- Meta 183 chars — truncates.
- H1 mirrors long title.
- OG image is generic moringa article image, not patches.

### Why Google doesn't love it
Query tokens users type (`Glorenda`, `Healrize`, `do they work`) are not reliably visible in the SERP title window. Softens query–document matching signals at click time.

### Why users don't love it
They scan for *their* brand name and a yes/no. They see a long AU/2026/scam stack first.

### Why AI doesn't love it
Headline entity order is weak; “scam” vs “unproven” creates a mild claim conflict with the BLUF.

### Exactly what should replace it
- **Title (≤60 chars target):** `Do Moringa Patches Work? Glorenda & Healrize Review`
- **H1:** `Do Moringa Patches Work? Glorenda, Healrize & Clearena`
- **Meta (~150 chars):** `Glorenda & Healrize patches lack human evidence for skin delivery. ARTG status, berberine risks, cost vs powder, and what to do if you already bought a pack.`
- **OG image:** photo of real patch packaging (or clearly labelled composite of brand packs you purchased / documented).

### Why the replacement is better
Matches head intent + brand queries; removes truncation; aligns headline with BLUF honesty; visual distinct from powder product spam in SERP.

### Priority
**P0**

### Expected impact
CTR on brand + “do they work” queries; cleaner AI headline extraction.

---

# 1. HEADER / BYLINE

### Current problem
`By Neer, NutriThrive Truganina · Last updated` — thin. No method line (“what we did / didn’t do”).

### Why Google doesn't love it
Experience signal is name-only; for YMYL-adjacent review, thin authorship.

### Why users don't love it
Don’t know if you bought patches, tested absorption, or only desk-researched.

### Why AI doesn't love it
No structured “methodology” chunk to cite as reviewer protocol.

### Exactly what should replace it
Byline block:
- Author + role (founder, packs powder in Truganina; not a doctor)
- **Method strip:** e.g. `Desk research + ARTG checks (date) + [purchased packs: yes/no] + no bloodwork/bioavailability assay`
- Disclosure one-liner *here* (not buried mid-page): sells powder, not patches.

### Why the replacement is better
Sets EEAT rules before claims; prevents “hidden seller” feeling; gives AI a quotable method.

### Priority
**P0**

### Expected impact
Trust; reduces bounce from skeptics who smell affiliate content.

---

# 2. BLUF VERDICT (red box)

### Current problem
Strong verdict, but **uncited**. Asserts “no published human clinical evidence” without showing how that was verified. Slightly dense for mobile first screen.

### Why Google doesn't love it
Strong medical-adjacent claim without outbound corroboration (page has **0 research hrefs**). Competitors like Medical News Today win trust by linking evidence culture even on adjacent topics.

### Why users don't love it
Power users want “prove the negative.” Casual users are fine — but best-in-class needs both.

### Why AI doesn't love it
Models hesitate to cite absolute negatives without sources; may prefer MNT/WebMD for safer grounding.

### Exactly what should replace it
Keep red BLUF structure, but:
1. One-sentence verdict unchanged in spirit.
2. Add **“How we checked (July 2026):”** — PubMed/Google Scholar search strings + “0 human transdermal moringa bioavailability hits” + link outs.
3. Separate **scam vs unproven** in two short lines (already partly there — sharpen).
4. Optional 20-word “Who this is for / not for.”

### Why the replacement is better
Makes the page the **definitive negative-evidence** source, not just a confident blog.

### Priority
**P0**

### Expected impact
AI Overview / Gemini citation; EEAT; defensible #1 for science intent.

---

# 3. QUICK ANSWER (green box)

### Current problem
Near-duplicate of BLUF. Three questions crammed in one paragraph. Good idea, redundant execution.

### Why Google doesn't love it
Duplicate answer blocks dilute which passage is canonical for snippets.

### Why users don't love it
Feels like the same text twice — slows “scan and go.”

### Why AI doesn't love it
Two competing answer chunks; retrieval may pick either arbitrarily.

### Exactly what should replace it
**Delete as separate box** OR convert to a **3-row answer table**:

| Question | Answer |
|----------|--------|
| Do they work? | No human evidence of meaningful systemic moringa via skin. |
| Are they a scam? | Usually overclaimed marketing, not proven criminal fraud. |
| What works instead? | Oral leaf powder 1.5–3 g/day (form used in human trials). |

Keep BLUF prose; Quick Answer becomes the **machine/skimmer table** only.

### Why the replacement is better
One human narrative + one extractable grid = best of both; no redundancy.

### Priority
**P1**

### Expected impact
Snippet/AI extract clarity; shorter first screen.

---

# 4. KEY TAKEAWAYS

### Current problem
Solid list. Item “4,000% search increase” is **unsourced** (lives again in body). “TikTok affiliate reviews…” is good but generic.

### Why Google doesn't love it
Unsourced statistics are quality liabilities.

### Why users don't love it
Impressive number without proof feels like marketing.

### Why AI doesn't love it
Won’t reliably cite a % claim without a chart/source.

### Exactly what should replace it
Keep 5 bullets max:
- Evidence status (with “as of [date], search method…”)
- ARTG status for named brands
- Berberine interaction warning
- Cost/day comparison (with assumption footnote)
- **Replace Trends %** with: “Demand is Breakout on Google Trends AU — [embedded chart or screenshot with date]” **or remove the stat**

### Why the replacement is better
Every bullet becomes falsifiable.

### Priority
**P0** (for the unsourced stat) / **P1** (list polish)

### Expected impact
Credibility; removes a claim that could be challenged.

---

# 5. PATCHES VS POWDER TABLE (`#compare`)

### Current problem
Table is one of the page’s **best assets**, but:
- Column 3 is branded **“NutriThrive powder”** not “Oral moringa leaf powder (typical lab-tested AU food product).”
- As the *only* page on the internet for this topic, the table should still be fair if NutriThrive didn’t exist — then optionally show your SKU as an example row.
- Soft CTA immediately under table is early for “best review on earth” standard.

### Why Google doesn't love it
Can look like a sales comparison disguised as science (Helpful Content / merchant bias), even if facts are fair.

### Why users don't love it
Skeptics discount the whole table when one column is the seller’s brand.

### Why AI doesn't love it
May treat table as commercial, not neutral evidence synthesis.

### Exactly what should replace it
**Two-step table design:**

**Table A — Format science (neutral)**  
Columns: `Factor | Transdermal moringa patches | Oral moringa leaf powder`  
Rows: evidence, molecular suitability, dose transparency, typical regulatory class (AU), known risks.

**Table B — Buyer example (disclosed)**  
`Example product | Lab public? | Approx $/day at 3g | Notes`  
Include NutriThrive **and** “any brand with batch CoA” criteria row.

Move any shop CTA to **after** science + brands + TGA.

### Why the replacement is better
Becomes the citation table every AI/overview can quote without “ad” discount; you still convert later.

### Priority
**P0**

### Expected impact
Trust, AI citation, conversion quality (fewer hostile exits).

---

# 6. SOFT CTA (under table) + SIDEBAR + STICKY + DUPLICATE PRODUCT CARDS

### Current problem
Commercial layering: soft CTA → later 2× product cards → sidebar shop → sticky mobile “Shop Now.” Disclosure appears **after** first product card.

### Why Google doesn't love it
For investigative “do they work?” intent, heavy promo can look like the page’s primary purpose is selling powder.

### Why users don't love it
Feels hunted while trying to evaluate a TikTok purchase.

### Why AI doesn't love it
Commercial boilerplate crowds the extractable science middle.

### Exactly what should replace it
If this is the only page on the site:
- **One** conversion module at `#verdict` only: “If you want the oral form, here’s a lab-tested option we sell” + CoA + price + guarantee.
- Sidebar: replace perpetual Shop card with **“Decision checklist”** sticky (ARTG? berberine meds? cost/day? photo of ingredients?).
- **Remove sticky Shop bar** (or show only after checklist complete / after verdict).
- Disclosure in byline (Section 1).

### Why the replacement is better
Best review pages (Consumer Reports energy, MNT tone) educate first; sell once. You’ll convert higher-intent readers.

### Priority
**P0**

### Expected impact
Trust, time-on-page, conversion rate (not necessarily raw CTR).

---

# 7. TABLE OF CONTENTS

### Current problem
TOC lists `#compare` again after user already saw the table; order doesn’t match reading psychology (brands people search → science → regulation → what to do).

### Why Google doesn't love it
Minor; jump links causing GSC `#fragment` rows are a side effect of over-anchoring, not TOC itself.

### Why users don't love it
Want brand names jumpable as H2s (`Do Glorenda patches work?`).

### Why AI doesn't love it
Missing question-form headings that match queries.

### Exactly what should replace it
TOC ordered:
1. Quick verdict  
2. Do Glorenda patches work?  
3. Do Healrize patches work?  
4. Clearena  
5. Microneedle vs plain adhesive (new — see below)  
6. Transdermal science + sources  
7. Berberine risks  
8. TGA/ARTG how-to-check  
9. Weight loss claims  
10. Chemist Warehouse confusion  
11. Already bought a pack  
12. Oral alternative (neutral then optional product)  
13. FAQ  

### Why the replacement is better
Mirrors real search intents; makes the page a full hub without other URLs.

### Priority
**P1**

### Expected impact
UX + query coverage + AI section retrieval.

---

# 8. WHAT ARE MORINGA PATCHES?

### Current problem
Decent explainer, then **unsourced 4,000% / Breakout** claims. Links out to berberine guide — **forbidden under “only page” constraint**; that content must be inlined or summarized with sources here. No photo of an actual patch.

### Why Google doesn't love it
Unsourced trend stats; thin multimedia vs YouTube competitors dominating SERP.

### Why users don't love it
Still don’t *see* the product category; abstract text loses to video unboxings.

### Why AI doesn't love it
Can’t ground the Trends claim; weak entity grounding without images/schema ImageObject of patches.

### Exactly what should replace it
- Definition + diagram: skin barrier vs gut absorption (simple original graphic).
- **Types:** plain adhesive “botanical” patches vs **microneedle / microdart** marketing (Amazon SERP shows this — you currently barely address it).
- Trends: screenshot with date **or delete**.
- Inline 6–8 lines on what berberine is (with DOI/PubMed), not a link away.
- Original or labelled photo of patch sheet.

### Why the replacement is better
Closes the gap vs YouTube/Amazon (people search microneedle variants); makes the page visually definitive.

### Priority
**P0** (microneedle + image + kill unsourced %) · **P1** (diagram)

### Expected impact
Compete with video SERPs; AI entity completeness; user comprehension.

---

# 9. BRAND CARDS (Glorenda / Healrize / Clearena)

### Current problem
H3 cards inside one H2 — too shallow for brand-query winners. Healrize/Clearena are thin paragraphs. No “we bought on [date] from [URL]” artifacts. No H2s shaped like queries.

### Why Google doesn't love it
Brand queries deserve dedicated, crawlable heading targets; thin unique content per entity.

### Why users don't love it
They typed a brand name; they get a stub.

### Why AI doesn't love it
Hard to cite a Glorenda-specific verdict distinct from Healrize.

### Exactly what should replace it
Promote each brand to **H2**:

**`## Do Glorenda patches work?`**  
- What they claim (quote label/ad, dated)  
- ARTG check result (screenshot or step-by-step + date)  
- Ingredients list if available  
- Evidence vs claims  
- Verdict line  

Same for Healrize and Clearena.  
Add **`## Other brands / white-label patches`** for Amazon generics.

If you did **not** purchase: state that explicitly; evaluation = claims + regulation + science only.

### Why the replacement is better
This is how a page becomes *the* Glorenda/Healrize destination, not a generic patches essay.

### Priority
**P0**

### Expected impact
Brand-query rankings/CTR; AI per-entity answers.

---

# 10. TRANSDERMAL SCIENCE SECTION

### Current problem
Best scientific writing on the page, but **no citations**. Mentions Dalton rules, polyphenols, animal berberine wound patches — all unsourced. Dates say June in body vs July updates elsewhere.

### Why Google doesn't love it
YMYL-adjacent science without references loses to Medical News Today / WebMD culture of citation.

### Why users don't love it
Can’t verify; must trust a powder seller’s chemistry lesson.

### Why AI doesn't love it
High desire to cite this paragraph type — blocked by missing sources.

### Exactly what should replace it
Keep the science-box concept; add:
1. Numbered mechanisms with **links** (review articles on transdermal requirements; oral moringa RCTs; berberine oral evidence; animal TD berberine if claimed — with “animal ≠ human systemic weight-loss” callout).
2. **“Search log” box:** databases, queries, date, result count.
3. Optional simple figure: molecule classes vs skin permeability (original).
4. Explicit: *local skin effect / placebo / systemic uptake* trichotomy.

### Why the replacement is better
Turns the page into the reference article others deep-link; AI can quote with grounding.

### Priority
**P0**

### Expected impact
#1 for science intent; AI Overview eligibility; EEAT.

---

# 11. COMMON MISTAKES

### Current problem
Good list. Slightly overlaps science + TGA. No “microneedle marketing” mistake. No “Chemist Warehouse confusion” mistake (that’s only in FAQ).

### Why Google doesn't love it
Fine section; not a weakness if unique mistakes stay unique.

### Why users don't love it
Lists without “what to do instead” per mistake.

### Why AI doesn't love it
List is citable; improve with imperative outcomes.

### Exactly what should replace it
Keep as numbered **mistakes → consequence → fix** triples. Add:
- Confusing Rosabella CW capsules with patches  
- Assuming microneedles = proven systemic delivery  
- Using overseas Amazon reviews as AU regulatory proof  

### Why the replacement is better
Matches real failure modes from SERP/affiliate ecosystem.

### Priority
**P2**

### Expected impact
Completeness; featured-list potential.

---

# 12. BERBERINE INTERACTION RISK

### Current problem
Important and relatively strong, but light on citations for metformin/CYP3A4/warfarin claims. Under “only page” rule, this must be self-contained with sources (currently points people away conceptually to “discuss with GP” only).

### Why Google doesn't love it
Drug-interaction claims are YMYL; need authoritative references (TGA, NIH, review papers).

### Why users don't love it
Scary without “what exactly should I ask my pharmacist?”

### Why AI doesn't love it
Will prefer sources that cite literature for interactions.

### Exactly what should replace it
- Interaction table: Drug class | Risk | Ask your pharmacist | Source link  
- Clear: **unknown transdermal dose ≠ safe**; oral berberine evidence ≠ patch dose known  
- Inline short “what berberine is” (from Section 8) cross-link anchor  
- GP script: 2 sentences patients can copy

### Why the replacement is better
Best-in-class safety section; reduces medical liability vagueness; highly citable.

### Priority
**P0**

### Expected impact
Trust; AI safety answers; differentiation vs hype pages.

---

# 13. TGA / ARTG SECTION

### Current problem
Correct direction; tells user to search ARTG but no **screenshot**, no **exact search terms**, no “last verified on DATE” per brand. Plain `tga.gov.au/artg` text not a hyperlink in the paragraph (user mentions it; FAQ schema discusses ARTG).

### Why Google doesn't love it
Experience/evidence thinner than a page that shows the check.

### Why users don't love it
Many won’t complete the ARTG task; they wanted you to show the result.

### Why AI doesn't love it
Can cite the rule; can’t cite your verification event without a dated artifact.

### Exactly what should replace it
- Step-by-step ARTG check (numbered)  
- Results table: Brand | ARTG found? | Date checked | Notes  
- Screenshot(s) of search results (even “no match”)  
- Distinguish **food** vs **therapeutic goods** with FSANZ/TGA links  
- “What enforcement means / doesn’t mean” (already partly there — keep)

### Why the replacement is better
Nobody else in the SERP does AU regulatory fieldwork this clearly.

### Priority
**P0**

### Expected impact
Unique EEAT moat; AU query dominance.

---

# 14. ALREADY BOUGHT BOX

### Current problem
Empathetic and useful, but pivots hard to “try our powder week” and links off-page for how-to. Under only-page rule, how-to must live here. Tone slightly salesy for anxious buyers.

### Why Google doesn't love it
OK UX; commercial tilt.

### Why users don't love it
Need: stop or continue? side effects to watch? dispose? GP triggers? — before “buy powder.”

### Why AI doesn't love it
Weak as a safety protocol chunk; strong as a sales bridge.

### Exactly what should replace it
**Decision flowchart (text/SVG):**
1. On metformin/warfarin/etc.? → stop + GP  
2. Skin reaction? → stop  
3. Otherwise optional finish pack (no proven benefit expected)  
4. If still want moringa benefits → oral powder protocol **on this page** (½ tsp → 1 tsp, with food, 7 days, what not to expect)  
5. Optional: link/button to buy *after* protocol

### Why the replacement is better
Becomes the best “I already ordered Glorenda” landing experience on the internet.

### Priority
**P1**

### Expected impact
User love; conversion after trust; fewer regret exits.

---

# 15. WHAT ACTUALLY WORKS (ORAL BENEFITS)

### Current problem
Iron “28mg/100g,” glucose study ranges, antioxidant claims — **mostly unsourced**. Risks overclaiming benefits while debunking patches (asymmetric evidence standard).

### Why Google doesn't love it
Debunk page that then asserts nutrition facts without citations looks inconsistent.

### Why users don't love it
Whiplash: “patches unproven” → “powder does iron/energy” without proof.

### Why AI doesn't love it
Won’t prefer unsourced nutrient claims vs WebMD/Healthline.

### Exactly what should replace it
- Strict rule: **every benefit bullet has a citation** or is removed.  
- Frame as: “What oral moringa research has studied (not guarantees).”  
- Mini table: Outcome | Evidence strength | Typical oral dose in studies | Source  
- Explicit non-claims (no weight-loss promise).  
- Because only page: include 1 smoothie / water mix method here (no outbound required).

### Why the replacement is better
Same evidence standard on both sides of the argument = best-page integrity.

### Priority
**P0**

### Expected impact
EEAT consistency; AI willingness to cite both halves.

---

# 16. PULL QUOTE / STAT (“$0.33/day”)

### Current problem
Effective CRO line; assumptions in small print only under table. Repeated with product cards.

### Why Google doesn't love it
Fine if assumptions clear; spammy if repeated 4×.

### Why users don't love it
Suspect number without pack-price sources for patches side.

### Why AI doesn't love it
Cost claims need dated price sources to cite.

### Exactly what should replace it
One **cost methodology box**: patch pack prices sampled (retailers, dates) → $/day range; powder $/day math; spreadsheet assumptions. One display of the number, not four.

### Why the replacement is better
Makes cost comparison journalistic, not slogan.

### Priority
**P1**

### Expected impact
Believability; CRO for switchers.

---

# 17. DISCLOSURE

### Current problem
Good text; **placed too late** (after product card).

### Why Google / users / AI don't love it
Late disclosure = classic affiliate pattern; discounts prior content.

### Exactly what should replace it
Move full disclosure to **byline**. Keep short reminder before the single final CTA.

### Why the replacement is better
Matches best-practice review ethics.

### Priority
**P0**

### Expected impact
Trust; Helpful Content alignment.

---

# 18. VERDICT

### Current problem
Strong narrative (Rosabella playbook parallel). Slightly AU-insider; “whether NutriThrive or another brand” is good. Still light on “what would change our mind” (falsifiability).

### Why Google doesn't love it
Good closing; not unique enough without falsifiability.

### Why users don't love it
Want a final decision box: Buy patches? No. Why? Exceptions?

### Why AI doesn't love it
Needs a crisp 40–60 word canonical verdict paragraph (partly exists).

### Exactly what should replace it
- **Verdict card:** Buy patches? **No** (for systemic moringa benefits).  
- **Would change our mind if:** human TD bioavailability study at clinical systemic levels; ARTG listing; published CoA; clear dose delivered.  
- Keep playbook insight; tone down sales.

### Why the replacement is better
Scientific humility + clear decision = best-in-class review ending.

### Priority
**P1**

### Expected impact
Memorable quotable ending; AI verdict extraction.

---

# 19. FAQ

### Current problem
Only **3** visible FAQs in HTML details; schema has more (7) — mismatch risk. Missing FAQs that match GSC demand: Glorenda safe? Healrize reviews? Weight loss patches CW? Microneedle? How long until results? Side effects?

### Why Google doesn't love it
Schema/visible inconsistency; missing query coverage.

### Why users don't love it
Their exact question absent.

### Why AI doesn't love it
FAQPage is prime citation fuel — underused.

### Exactly what should replace it
Expand visible FAQs to match schema 1:1 (8–12):
- Do moringa patches work?  
- Do they work for weight loss?  
- Do Glorenda patches work?  
- Do Healrize patches work?  
- Are they at Chemist Warehouse?  
- Are they TGA/ARTG approved?  
- Are they safe with metformin?  
- Microneedle patches different?  
- Can I use powder instead? (neutral then optional product)  
- What if I already bought them?  

Each answer ≤80 words + anchor to deep section.

### Why the replacement is better
Owns the long-tail; feeds AI Overview FAQ blocks.

### Priority
**P0**

### Expected impact
Long-tail SEO; AI; CTR from rich results (if eligible).

---

# 20. RELATED GUIDES

### Current problem
Six outbound links to other blogs. **Invalid under “only page on the website” constraint** — also trains users/Google that authority is elsewhere.

### Why Google doesn't love it
Dilutes “this URL is complete.”

### Why users don't love it
Forces tab hopping mid-decision.

### Why AI doesn't love it
May cite child pages instead of this hub.

### Exactly what should replace it
Delete external “related guides” list. Replace with **“Covered on this page”** mini-TOC of the new H2s. If product exists, one line to product URL is allowed as commerce, not as information offload.

### Why the replacement is better
Forces completeness; makes this URL the entity home.

### Priority
**P0** (for this thought experiment / best-page goal)

### Expected impact
Topical completeness; ranking consolidation onto one URL.

---

# 21. MEDIA / VIDEO / SCHEMA / TECHNICAL

### Current problem
- No explainer video (YouTube owns SERP real estate).  
- No ImageObject of patches.  
- BlogPosting + FAQ good; no VideoObject.  
- Generic OG.  
- Fragment-heavy anchors.

### Why Google doesn't love it
Video + image competitors satisfy engagement formats you lack.

### Why users don't love it
Prefer 60–90s “show me the patch / ARTG / powder” video.

### Why AI doesn't love it
Multimodal less grounded; fewer captionable assets.

### Exactly what should replace it
- 60–90s original video: verdict + ARTG + powder teaspoon (host on page + transcript).  
- VideoObject + transcript section.  
- 3–5 original images with accurate alt.  
- Keep FAQ/BlogPosting; sync FAQ.  
- Canonical already good — keep.

### Why the replacement is better
Matches how the actual SERP behaves in 2026 while keeping evidence soul.

### Priority
**P1** (video) · **P0** (images + FAQ sync)

### Expected impact
SERP competitiveness vs YouTube; engagement; AI.

---

# MASTER BUILD ORDER (for this page only)

| Step | Sections | Priority |
|------|----------|----------|
| 1 | Byline method + early disclosure; kill/move early CTAs; single end CTA | P0 |
| 2 | Neutral science table + cited science + search log | P0 |
| 3 | Brand H2s + ARTG dated proof | P0 |
| 4 | Title/meta/H1 + OG patch image | P0 |
| 5 | FAQ expansion synced to schema | P0 |
| 6 | Microneedle subsection + diagram | P0–P1 |
| 7 | Already-bought flowchart + on-page oral protocol | P1 |
| 8 | Cost methodology box; verdict falsifiability | P1 |
| 9 | Original video + transcript | P1 |
| 10 | TOC reorder; remove related outbound guides | P0–P1 |

---

# WHAT “BEST ON THE INTERNET” LOOKS LIKE WHEN DONE

A reader (or model) can leave with:
1. A sourced verdict on systemic efficacy  
2. Brand-specific answers  
3. AU regulatory status with dated proof  
4. Drug-interaction caution with sources  
5. Microneedle vs adhesive clarity  
6. A post-purchase protocol  
7. A fair cost comparison  
8. One honest commercial option for oral powder — clearly labelled  

…without opening Trustpilot, Amazon, YouTube, or another NutriThrive URL for the core decision.

---

**Next step when you say go:** implement in the build order above (start Step 1–3), still without expanding into other blog URLs.
